Botulinum toxin type A as an adjuvant treatment modality for extensive Hailey-Hailey disease

Journal of Dermatological Treatment

Volumn 19, Issue 4, 2008, Pages 251-254

  Koeyers, Wendy Jane ^a   Van Der Geer, Simone ^a   Krekels, Gertruud ^a  

^a CATHARINA HOSPITAL   (Netherlands)

Author keywords

Benign familial pemphigus; Botulinum toxin type A; BTXA; Hailey Hailey disease; HH disease

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BOTULINUM TOXIN A; CORTICOSTEROID;

ADULT; AGED; ANAMNESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HAILEY HAILEY DISEASE; HISTOPATHOLOGY; HUMAN; MALE; PRIORITY JOURNAL; SKIN DEFECT;

ADULT; AGED; BOTULINUM TOXIN TYPE A; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PEMPHIGUS, BENIGN FAMILIAL;

EID: 48249100430     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630801955135     Document Type: Article

References (20)

1. Missiaen L, Dode L, Vanoevelen J, Raeymaekers L, Wuytack F. Calcium in the Golgi apparatus. Cell Calcium. 2007;41:405-16.
2. Burge SM. Hailey-Hailey disease: The clinical features, response to treatment and prognosis. Br J Dermatol. 1992;126:275-82.
3. Mashiko M, Cunningham NM. Bacterial infection-induced generalized Hailey-Hailey disease successfully treated by etretinate. Clin Exp Dermatol. 2006;31:57-9.
4. Bianchi L, Chimenti MS, Giunta A. Treatment of Hailey-Hailey disease with topical calcitriol. J Am Acad Dermatol. 2004;51:475-6.
5. Rajpara SM, King CM. Hailey-Hailey disease responsive to topical calcitriol. Br J Dermatol. 2005;152:816-17.
6. Rabeni EJ, Akiyama M, Tsuji-Abe Y, Shimizu H. Effective treatment of Hailey-Hailey disease with topical tacrolimus. J Am Acad Dermatol. 2002;47:797-8.
7. Sand C, Thomsen HK. Topical tacrolimus ointment is an effective therapy for Hailey-Hailey disease. Arch Dermatol. 2003;139:1401-2. 8. Laffitte E, Panizzon RG. Is topical tacrolimus really an effective therapy for Hailey-Hailey disease? Arch Dermatol. 2004;140:1282.
8. Touma DJ. Benign familial pemphigus. Treatment with the pulsed carbon dioxide laser. Dermatol Surg. 1998;24:1411-14.
9. Christian MM, Moy RL. Treatment of Hailey-Hailey disease (or benign familial pemphigus) using short pulsed and short dwell time carbon dioxide lasers. Dermatol Surg. 1999;25:661-3.
10. Collet Villette AM, Richard MA, Fourquet F, Monestier S, Gaudy C, Bonerandi JJ, et al. Treatment of Hailey-Hailey disease with carbon dioxide laser vaporization. Ann Dermatol Venereol. 2005;132:637-40.
11. Konig A, Hörster S, Vakilzadeh F, Happle R. Type 2 segmental manifestation of Hailey-Hailey disease: Poor therapeutic response to dermabrasion is due to severe involvement of adnexal structures. Eur J Dermatol. 2000;10:265-8.
12. Menz P, Jackson IT, Connolly S. Surgical control of Hailey-Hailey disease. Br J Plast Surg. 1987;40:557-61.
13. Lapiere J. Botulinum toxin type A for the treatment of axillary Hailey Hailey. Dermatol Surg. 2000;26:371-4.
14. Konrad H. Intracutaneous botulinum toxin type A versus ablative therapy of Hailey Hailey disease. A case report. J Cosmet Laser Ther. 2001;3:181-4.
15. Kang NG, Yoon TJ, Kim TH. Botulinum toxin type A as an effective adjuvant therapy for Hailey-Hailey disease. Dermatol Surg. 2002;28:543-4.
16. Wollina U, Konrad H, Petersen S. Botulinum toxin in dermatology - beyond wrinkles and sweat. J Cosmet Dermatol. 2005;4:223-7.
17. Bansal C, Omlin KJ, Hayes CM, Rohrer TE. Novel cutaneous uses for botulinum toxin type A. J Cosmet Dermatol. 2006;5:268-72.
18. Naumann M. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: Randomised, parallel group, double blind, and placebo controlled trial. BMJ. 2001;323:1-4.
19. Lowe N. The place of botulinum type A in the treatment of focal hyperhidrosis. Br J Dermatol. 2004;151:1115-22.
20. Wollina U. High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval. J Am Acad Dermatol. 2002;46:536-40.